Cambridge Investment Research Advisors’s Alger AI Enablers & Adopters ETF ALAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
54,510
+3,534
+7% +$147K 0.01% 1505
2026
Q1
$1.68M Buy
50,976
+2,077
+4% +$72.7K ﹤0.01% 1734
2025
Q4
$1.77M Buy
48,899
+9,877
+25% +$365K ﹤0.01% 1640
2025
Q3
$1.46M Buy
39,022
+15,499
+66% +$520K ﹤0.01% 1752
2025
Q2
$726K Buy
23,523
+8,574
+57% +$223K ﹤0.01% 2212
2025
Q1
$342K Buy
14,949
+4,671
+45% +$122K ﹤0.01% 2755
2024
Q4
$270K Buy
+10,278
New +$261K ﹤0.01% 2922

Other funds holding ALAI

Cambridge Investment Research Advisors's ALAI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Alger AI Enablers & Adopters ETF (ALAI) stake by 6.9% in Q2 2026, buying an estimated $147K and bringing the position to 54,510 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #1505.

Cambridge Investment Research Advisors first reported a position in ALAI in Q4 2024 and has held it in 7 quarters since. 85 funds tracked by Wall St. Rank hold ALAI as of Q2 2026.

  • Cambridge Investment Research Advisors held 54,510 shares of Alger AI Enablers & Adopters ETF worth $2.49M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,534 Alger AI Enablers & Adopters ETF shares in Q2 2026, an estimated $147K.
  • Alger AI Enablers & Adopters ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1505 holding.
  • Cambridge Investment Research Advisors first reported a position in Alger AI Enablers & Adopters ETF in Q4 2024 and has held it in 7 quarters since.
  • 85 funds tracked by Wall St. Rank held Alger AI Enablers & Adopters ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.